Subject: Growth Hormone (GH) Therapy*. Effective Date: July 29, 2003. Department(s): Utilization Management. Policy: Treatment with GH (HCPCS J2941) is reimbursable under Plans. administered by QualCare, Inc. for the indications listed below. Objective: To provide proper and consistent reimbursement for and to ensure.
Branch and is intended to preserve the role of CRS as a confidential resource. decision whether and how to place individual CRS products in the public domain. congressional publications, or through their own web sites. CRS for individual congressional clients, should be maintained. interpreted broadly.
reached, prepares the House Ways and Means Committee report. The report includes the proposed bill drafted in legislative language, an assessment of its effect on revenue and a general explanation of the provisions in the bill. Since the report is the only written document that details the reasons for the committee's